Phoenixville, PA, United States of America

John R Chippari

This inventor holds 3 USPTO granted patents. Top assignees: Elan Pharma International Limited, Alkermes Pharma Ireland Limited. Active years: 2007-2012.


Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Phoenixville, PA (US) (2007)
  • Phonenixville, PA (US) (2010 - 2012)

Company Filing History:


Years Active: 2007-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: John R. Chippari: Innovator in Pharmaceutical Evaluation

Introduction

John R. Chippari is a notable inventor based in Phoenixville, PA (US). He has made significant contributions to the field of pharmaceutical evaluation, particularly in the development of methods for assessing the effectiveness of drug formulations. With a total of 3 patents to his name, Chippari's work has had a meaningful impact on the industry.

Latest Patents

Chippari's latest patents focus on in vitro methods for evaluating the in vivo effectiveness of dosage forms containing microparticulate or nanoparticulate active agent compositions. These patents disclose innovative methods for assessing the redispersibility of dosage forms of poorly water-soluble active agents. The methods utilize media that are representative of in vivo human physiological conditions, providing a more accurate evaluation of drug performance.

Career Highlights

Throughout his career, John R. Chippari has worked with prominent companies in the pharmaceutical sector, including Elan Pharma International Limited and Alkermes Pharma Ireland Limited. His experience in these organizations has allowed him to refine his expertise in drug formulation and evaluation.

Collaborations

Chippari has collaborated with several professionals in his field, including Eugene Rex Cooper and John A. Bullock. These collaborations have contributed to the advancement of his research and the development of his patented methods.

Conclusion

John R. Chippari's innovative work in pharmaceutical evaluation has led to the development of valuable methods that enhance the understanding of drug effectiveness. His contributions continue to influence the industry and pave the way for future advancements in drug formulation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…